| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 07/15/2008 | US7399763 and highly specific HIV replication inhibitor; ethyl 2-benzyl-8-hydroxy-1-oxo-1,2,3,4-tetrahydropyrrolo[1,2- alpha ]pyrazine-7-carboxylate; aquired immune deficiency syndrome (AIDS) |
| 07/15/2008 | US7399432 Charge transport compositions and electronic devices made with such compositions |
| 07/15/2008 | CA2286797C A process for the preparation of highly pure 6,7-dichloro-5-nitro-2,3-dihydroquinoxaline-2,3-dione |
| 07/15/2008 | CA2279620C 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands (d4) |
| 07/10/2008 | WO2008083346A1 Phenazine and quinoxaline substituted amino acids and polypeptides |
| 07/10/2008 | WO2008082887A2 Inhibitors of poly(adp-ribose)polymerase |
| 07/10/2008 | WO2008080824A1 Aromatic sulfonated ketals |
| 07/10/2008 | WO2008080823A1 Reduction methodologies for converting ketal acids, salts, and esters to ketal alcohols |
| 07/10/2008 | WO2008080268A1 Derivates of substituted tartaric aicd and usage for preparating beta secretase inhibitors |
| 07/10/2008 | WO2008022046B1 Dicer substrate rna peptide conjugates and methods for rna therapeutics |
| 07/10/2008 | US20080167466 Capped pyrazinoylguanidine sodium channel blockers |
| 07/10/2008 | US20080167465 Electrochromic compound |
| 07/10/2008 | US20080167307 Carboxylic Acid Derivative Containing Thiazole Ring and Pharmaceutical Use Thereof |
| 07/10/2008 | US20080167301 Novel Hydroxy-6-Heteroarylphenanthridines and Their Use as Pde4 Inhibitors |
| 07/10/2008 | US20080167288 Substituted cyclic hydroxamates as lnhibitors of matrix metalloproteinases |
| 07/10/2008 | US20080166593 Organic Electroluminescent Devices |
| 07/10/2008 | CA2672860A1 Inhibitors of poly(adp-ribose)polymerase |
| 07/10/2008 | CA2671851A1 Phenazine and quinoxaline substituted amino acids and polypeptides |
| 07/09/2008 | EP1942106A1 Therapeutic agents useful for treating pain |
| 07/09/2008 | EP1940805A1 Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase |
| 07/09/2008 | EP1940387A1 Process for the stereoselective preparation of (-)-halofenate and intermediates thereof |
| 07/09/2008 | EP1379251B1 Inhibitors of akt activity |
| 07/09/2008 | CN101218237A Oxime derivative and preparations thereof |
| 07/09/2008 | CN101217957A 2,3 substituted pyrazine sulfonamides as inhibitors of CRTH2 |
| 07/09/2008 | CN101215299A Quinoxalines ligand iridium complexes and synthetic method thereof |
| 07/09/2008 | CN101215266A Chlorination preparation method for quinoxaline derivatices |
| 07/09/2008 | CN101215265A Method for integrally extracting and purifying ligustrazine, ferulic acid and volatile oil in ligusticum wallichii |
| 07/09/2008 | CN100400522C Novel charge transport materials having heteroaromatic hydrazone groups |
| 07/09/2008 | CN100400519C N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines |
| 07/09/2008 | CN100400487C Glucocorticoid receptor modulators |
| 07/08/2008 | US7396833 Indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof |
| 07/08/2008 | US7396832 Inhibitors of Akt activity |
| 07/08/2008 | US7396831 Vanilloid receptor ligands and their use in treatments |
| 07/03/2008 | WO2008078674A1 Glucokinase-activating substance |
| 07/03/2008 | US20080161566 Crystal and Salt of 1-Cyclopropylmethyl-4-[2-(3,3,5,5-Tetramethylcyclohexyl)Phenyl]Piperazine |
| 07/03/2008 | US20080161565 Coupling [4-(1,3,4-oxadiazol-2-yl)phenyl]boronic acid with N-(Isobutoxycarbonyl) N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl) Pyridine-3-sulphonamide, producing N-(isobutoxycarbonyl) N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide |
| 07/03/2008 | US20080161564 Aromatic sulfonated ketals |
| 07/03/2008 | US20080161563 Reducing ketal acid with a hydride reducing agent in a hydrophobic solvent to a ketal alcohol, quenching the reduction reaction;washing, extracting the ketal alcohol into the back-extracting hydrophobic solvent |
| 07/03/2008 | US20080161325 e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome |
| 07/03/2008 | US20080161313 7-{4-[2-(2,6-dichloro-4-methylphenoxy)ethoxy]phenyl}-3,9-diazabicyclo[3.3.1]non-6-ene-6-carboxylic acid cyclopropyl-(2,3-dimethylbenzyl)amide; retin inhibitor with other active ingredients; cardiovascular diseases and renal insufficiency |
| 07/03/2008 | US20080161312 Derivatives of Pyrrolo-Pyrazines Having a Kinase Inhibitory Activity and Their Biological Applications |
| 07/03/2008 | US20080161292 Inhibitors of poly(adp-ribose)polymerase |
| 07/03/2008 | US20080161271 e.g. 9-Hydroxy-2-(2-methoxy-ethyl)-1,8-dioxo-1,8-dihydro-2H-pyrid[1,2-a]pyrazi ne-7-carboxylic acid 4-fluoro-banzylamide; Human T cell leukemia virus, Feline and Simian immunodeficiency virus inhibitor; side effects reduction |
| 07/03/2008 | CA2673466A1 Substituted tetracycline compounds |
| 07/03/2008 | CA2672088A1 Glucokinase activator |
| 07/03/2008 | CA2664118A1 Protease inhibitors |
| 07/02/2008 | EP1939189A1 Derivative having ppar agonistic activity |
| 07/02/2008 | EP1214287B1 Amides as inhibitors for pyruvate dehydrogenase |
| 07/02/2008 | CN101212903A Polycyclic carbamoylpyridone derivative having HIV integrase inhibitory activity |
| 07/02/2008 | CN100398154C Remedies for psychoneurosis |
| 07/02/2008 | CN100398103C Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 07/01/2008 | US7393852 analgesics; antiinflammatory agents; antiarthritic agents;Alzheimer's disease; cirrhosis; antiallergens; antihistamines ; anticancer agents; vision defects |
| 07/01/2008 | US7393849 N-[4-Amidinobenzoyl]-N-[3-phenoxybenzyl]-3-(4-biphenyl)-alanyl-glycyl-amide; anticarcinogenic, antidiabetic, anticholesterol agent, cardiovascular disorders, osteoporosis |
| 06/26/2008 | WO2008076685A2 Process for the preparation of piperazinyl and diazepanyl benzamide derivatives |
| 06/26/2008 | WO2008075757A1 N-hydroxyacrylamide compounds |
| 06/26/2008 | WO2008074997A1 Pyridine benzamides and pyrazine benzamides used as pkd inhibitors |
| 06/26/2008 | WO2008074694A1 Crystallization of glucokinase activators |
| 06/26/2008 | WO2008074450A2 Non-peptidic renin inhibitors nitroderivatives |
| 06/26/2008 | WO2008002820A3 Substituted benzyl amine compounds |
| 06/26/2008 | US20080153850 Adamantyl Derivates as P2x7 Receptor Antagonists |
| 06/26/2008 | US20080153848 Crystalline Base of Trans-1-((1R,3S)-6-Chloro-3-Phenylindan-1-Yl)-3,3-Dimethylpiperazine |
| 06/26/2008 | US20080153847 Process for Making Trans-1-((1R,3S)-6-Chloro-3-Phenylindan-1-Yl)-3,3-Dimethylpiperazine |
| 06/26/2008 | US20080153843 Bradykinin 1 receptor (B1R) antagonists for treating various inflammatory diseases, pain, obesity; compounds bind to both rat and human receptors for pharmacological testing; ether and amide-functional N-heterocycle sulfonamides |
| 06/26/2008 | US20080153836 1H-Quinazoline-2,4-Diones |
| 06/26/2008 | US20080153835 Therapeutic agents useful for treating pain |
| 06/26/2008 | US20080153826 substituted aryl cycloalkanoyl derivatives, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorder |
| 06/26/2008 | US20080153823 a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy |
| 06/26/2008 | DE10354860B4 Halogenierte oder pseudohalogenierte monomere Phenaziniumverbindungen, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltendes saures Bad und Verfahren zum elektrolytischen Abscheiden eines Kupferniederschlages Halogenated or pseudo-halogenated monomeric phenazinium, process for their preparation and compounds containing acidic bath and method for electrolytically depositing a copper deposit |
| 06/26/2008 | CA2673582A1 Pyridine benzamides and pyrazine benzamides used as pkd inhibitors |
| 06/26/2008 | CA2672661A1 Process for the preparation of piperazinyl and diazepanyl benzamide derivatives |
| 06/26/2008 | CA2671993A1 N-hydroxyacrylamide compounds |
| 06/25/2008 | EP1935887A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
| 06/25/2008 | EP1934233A1 Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes |
| 06/25/2008 | EP1934180A2 3-cyclyl-2-(4-sulfamoyl-phenyl)-n-cyclyl-propionamide derivatives useful in the treatment of impaired glucose tolerance and diabetes |
| 06/25/2008 | EP1730127B1 Heterocyclic phenylaminopropanol derivatives as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (vms) |
| 06/25/2008 | EP1606266A4 Chemical compounds |
| 06/25/2008 | EP1492534B1 Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors |
| 06/25/2008 | EP1458393B1 Substituted diketopiperazines as oxytocin antagonists |
| 06/25/2008 | CN101208311A Pyrazine -2-carboxamide derivatives as mglur5 antagonists |
| 06/25/2008 | CN100396679C Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 06/24/2008 | US7390908 Such as 2-[3,5-Di(2-chlorobenzyloxy)benzoyl)amino]-thiazole; for treatment of diabetes |
| 06/24/2008 | US7390907 Vanilloid receptor ligands and their use in treatments |
| 06/19/2008 | WO2008073305A1 6-oxo.-1, 6-dihydropyrimidin-2-yls in the treatment of proliferative diseases |
| 06/19/2008 | WO2008072586A1 Material for organic electroluminescent device and organic electroluminescent device |
| 06/19/2008 | US20080146740 Process for the controlled increase in the molecular weight of polyethylenes |
| 06/19/2008 | US20080146588 Piperidinyl Piperidine Tachykinin Receptor Antagonists |
| 06/19/2008 | US20080146586 antitumor and antibiotic activity which can be used as anticancer agents; exhibit specific and intensive activity in inhibiting tyrosine kinase of the growth factor receptor, and show negligible side-effects compared |
| 06/19/2008 | US20080146580 Anititumoral Ecteinascidin Derivatives |
| 06/19/2008 | US20080146572 N-sulfonylurea apoptosis promoters |
| 06/19/2008 | US20080146566 treatment of diseases mediated by cytokines; N-cyclopropyl-4-methyl-3-(1-oxoisoquinolin-2(1H)-yl)benzamide; rheumatoid arthritis, asthma, chronic obstructive pulmonary disease, inflammatory bowel disease, multiple sclerosis, AIDS, septic shock, congestive heart failure, ischaemic heart disease, psoriasis |
| 06/19/2008 | CA2670726A1 6-oxo-1, 6-dihydropyrimidin-2-yls in the treatment of proliferative diseases |
| 06/18/2008 | EP1931645A2 N- (3-amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors |
| 06/18/2008 | EP1931644A2 Acenaphthoquinoxaline sulfonamide derivatives, optical crystal film and method of production thereof |
| 06/18/2008 | EP1931631A1 1- (1h- indol- 1-yl) -3- (methylamino) -1- phenylpropan-2-ol derivatives and related compounds as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (vms) |
| 06/18/2008 | EP1931627A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands |
| 06/18/2008 | CN100395293C Water-soluble fiber-reactive dyes, method for the production and use thereof |
| 06/17/2008 | US7388013 Capped pyrazinoylguanidine sodium channel blockers |
| 06/17/2008 | US7388008 (1-{5-[(4-amino-benzenesulfonyl)-isobutyl-amino]-6-phosphonooxy-hexacarbomoyl}-2,2-diphenyl-ethyl)-carbamic acid methyl ester; which upon cleavage of cleavable bond or unit generates HIV-1 aspartyl protease inhibitor; antiviral agent; good solubility, and bioavailability; HIV or HTLV infection |
| 06/12/2008 | WO2008068423A2 P<0}{0pyrrol derivatives, preparation and use of the same in therapy<0} |
| 06/12/2008 | US20080139811 Reacting an amino, hydroxy substituted amide with a heterocyclic substituted carboxylic acid to produce (2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl) amino-3-hydroxy-5-[2S-1-imidazolidin-2-onyl)-3-methyl-butanoyl] amino-1,6-diphenylhexane; inhibitors of HIV infection |